Highest-materiality recent filing
IDEX Q1 adj. EPS $2.00 (+14% YoY); raises FY organic growth to 3-4% from 1-2%; record orders $988M
Sales $887M (+9% reported, +5% organic); record orders $988M (+13% reported, +10% organic).
IDEX Q4 record sales $899M (+4%), adjusted EPS $2.10 (+3%); FY 2026 guidance: adj. EPS $8.15-$8.35
Q4 sales $899M, +4% reported (+1% organic); record orders $979M, +20% reported (+16% organic).
IDEX appoints Sean Gillen as CFO, effective Jan 5, 2026; CHRO Melissa Flores departing
Sean Gillen named SVP & CFO, effective Jan 5, 2026; Akhil Mahendra returns to VP Corporate Development.
IDEX Q3 record sales $879M (+10% YoY); adj EPS $2.03 (+7%); narrows FY outlook
Record sales $879M (+10% reported, +5% organic); record orders $880M (+13% reported, +7% organic).
IDEX increases share repurchase authorization to $1B and declares $0.71 quarterly dividend
Board authorized additional $635M share repurchase; total available now ~$1B including $365M remaining.
IDEX Q2 record sales $865M (+7%); cuts FY adjusted EPS guidance to $7.85-$7.95
Q2 reported diluted EPS $1.74 (-6% YoY); adjusted EPS $2.07 (flat YoY), beating expectations.
On May 20, 2025, the Company appointed Akhil Mahendra as interim Chief Financial Officer of the Company, effective May 30, 2025, to hold the position of interim Chief Financial Officer until his successor is appointed.
On May 19, 2025, Abhishek Khandelwal, Senior Vice President and Chief Financial Officer of IDEX Corporation (the “Company”), notified the Company of his decision to resign from his position, effective May 30, 2025, to pursue a new professional opportunity.
Max materiality 0.80 · Median 0.70 · Most common event earnings